+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07761910

Evaluation of Radiation-Induced Heart Damage Using PET-CT in Locally Advanced Non-Small Cell Lung Cancer Patients

Led by Indiana University · Updated on 2026-09-15

10

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating heart damage caused by standard chemotherapy and radiation treatment in patients with locally advanced Non-Small Cell Lung Cancer NSCLC. The study aims to understand long-term heart problems that may result from radiation therapy and focuses on protecting parts of the heart during treatment. This is a phase 2 clinical trial using advanced imaging to assess early signs of heart damage. Participants will undergo a special type of PETCT scan using 18F-Flurpiridaz to measure blood flow in the heart muscle. These scans will be done before and three months after receiving standard radiation therapy and chemotherapy. The study also uses Coronary CT Angiography CCTA to detect coronary artery plaque, providing a detailed look at heart health. During the study, participants will have PETCT scans at rest and under stress induced by regadenoson. Researchers will measure changes in myocardial blood flow and myocardial flow reserve to assess heart function before and after radiation therapy. The total follow-up period includes assessments up to three months post-radiation. Safety checks such as electrocardiograms EKG will be performed before stress testing, and participants will be closely monitored throughout the study.

CONDITIONS

Brief Title

Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Research Team

J

Jessica Anders

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here